News

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...
Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in patients taking these medications. The drugs may ...
Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.
Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...
Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...